Stock listing

Cardiol Therapeutics Inc. Class A (CRDL) Stock Price, News, Filings & Events

Selected listing: CRDL · TSX · CAD · CA

CRDL:TSX is the primary listing for Cardiol Therapeutics Inc. Class A, a Canadian public company with a market capitalization of approximately $122.3 million. The company is dedicated to developing innovative therapies for cardiovascular diseases, targeting significant unmet medical needs. Recent news and filings may provide insights into its ongoing research and development efforts, as well as any upcoming events that could impact its market presence.

websiteCRDL:TSXCADCASEO content: aiUpdated June 24, 2026/stock/tsx-crdl/cardiol-therapeutics-inc-class-a/l-xlut3allzr
Cardiol Therapeutics Inc. Class A logo
Ticker
CRDL:TSX
Asset type
Stock
Market cap
$122.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
TSX
Currency
CAD

Cardiol Therapeutics Inc. Class A CRDL:TSX stock context

CRDL:TSX is the primary listing for Cardiol Therapeutics Inc. Class A, a Canadian public company with a market capitalization of approximately $122.3 million. The company is dedicated to developing innovative therapies for cardiovascular diseases, targeting significant unmet medical needs. Recent news and filings may provide insights into its ongoing research and development efforts, as well as any upcoming events that could impact its market presence.

Research Cardiol Therapeutics Inc. Class A

Alternate listings